Forte Biosciences
FBRX
38 hedge funds and large institutions have $89.2M invested in Forte Biosciences in 2017 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.1% more ownership
Funds ownership: 0% → 0.1% (+0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$22.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$19.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12M |
| 4 |
BlackRock
New York
|
+$11.6M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$11.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
TD Asset Management
Toronto,
Ontario, Canada
| $158K | +$197K | +35 | New |
|
27
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $126K | +$158K | +28 | New |
|
28
New York State Common Retirement Fund
Albany,
New York
| $108K | +$135K | +24 | New |
|
|
AIG
29
American International Group
New York
| $63K | +$78.8K | +14 | New |
|
|
NFA
30
Nationwide Fund Advisors
Columbus,
Ohio
| $57K | +$73.1K | +13 | New |
|
|
SO
31
STRS Ohio
Columbus,
Ohio
| $30K | +$39.4K | +7 | New |
|
32
UBS Group
Zurich,
Switzerland
| $17K | +$22.5K | +4 | New |
|
33
Legal & General Group
London,
United Kingdom
| $15K | +$16.9K | +3 | New |
|
34
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $12K | +$16.9K | +3 | New |
|
35
BNP Paribas Financial Markets
Paris,
France
| $10.6K | +$11.3K | +2 | New |
|
|
PAM
36
Panagora Asset Management
Boston,
Massachusetts
| $10K | +$11.3K | +2 | New |
|
|
AIP
37
Ameritas Investment Partners
Lincoln,
Nebraska
| $9K | +$11.3K | +2 | New |
|
|
IP
38
Isthmus Partners
Madison,
Wisconsin
| $6K | +$5.63K | +1 | New |
|
39
Citigroup
New York
| $1K | – | – | – |
|
FBRX Hedge Fund Activity: Q2 2017 in Review
38 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2017, worth a combined $89.2M.
Buyers outnumbered sellers: 38 funds opened new FBRX positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $22.5M.
- 38 institutional investors held Forte Biosciences (FBRX) as of Q2 2017, up from 0 in Q1 2017.
- Funds reported $89.2M of Forte Biosciences stock for Q2 2017.
- 38 funds opened new Forte Biosciences positions in Q2 2017 and 0 closed out, a net change of +38 holders.
- The largest Forte Biosciences buyer in Q2 2017 was EcoR1 Capital, an estimated $22.5M added.
Based on aggregated 13F filings for Q2 2017.